| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $76.3M | +2.2% |
| Cost of Revenue | $9.3M | +1.2% |
| R&D Expense | $15.3M | -39.7% |
| SG&A Expense | $107.6M | +1.0% |
| Operating Income | -$55.9M | +15.9% |
| Interest Expense | $16.8M | +5.4% |
| Pre-tax Income | -$74.8M | +9.1% |
| Net Income | -$74.8M | +9.1% |
| EPS (Basic) | -$0.87 | +40.0% |
| EPS (Diluted) | -$0.87 | +40.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $33.9M | -4.3% |
| Inventory | $9.4M | -20.3% |
| Current Assets | $140.5M | -12.4% |
| Total Assets | $144.2M | -13.2% |
| Current Liabilities | $178.7M | +201.7% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $200.8M | +6.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$67.7M | +12.1% |
| Capital Expenditures | $63K | -62.3% |
| Investing Cash Flow | -$63K | -1.6% |
| Financing Cash Flow | $51.4M | +18.7% |
| Free Cash Flow | -$67.7M | +12.2% |
| Stockholders' Equity |
| -$56.6M |
| -160.1% |